Analysis of molecular biology techniques for the diagnosis of human papillomavirus infection and cervical cancer prevention

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 39, Issue 5, 2006, Pages 428-432

  Carestiato, Fernanda Nahoum ^a   Da Silva, Kátia Cristina ^a   Balthazar, Daniela Signorelli ^a   Silva, Licínio ^a   Marinho, Marisa ^b   Oliveira, Ledy Horto Dos Santos ^a   Cavalcanti, Silvia Maria Baeta ^a  

^a FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^b Laboratorio Sergio Franco   (Brazil)

Author keywords

Cancer; Human papillomavirus; Hybrid capture; Polymerase chain reaction; Squamous intraepithelial neoplasia

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER PREVENTION; CONTROLLED STUDY; CYTOPATHOLOGY; DNA HYBRIDIZATION; FEMALE; GENE AMPLIFICATION; GENETIC ANALYSIS; GENITAL SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; MOLECULAR BIOLOGY; POLYMERASE CHAIN REACTION; SQUAMOUS EPITHELIUM; UTERINE CERVIX CANCER; VIRUS GENE; VIRUS GENOME; VIRUS INFECTION; VIRUS LOAD; WART VIRUS;

HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRIDAE; SERGIO;

EID: 33845498857     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0037-86822006000500002     Document Type: Article

References (23)

1. Castle PE, Lorincz AT, Lohnas IM, Scott DR, Glass AG, Sherman ME, Schussler JE, Schiffman M. Results of human papillomavirus DNA testing with the hybrid capture II assay are reproducible. Journal of Clinical Microbiology 40: 1088-1090, 2002.
2. Castle PE, Schiffman M, Weeler CM. Hybrid capture 2 viral load and the 2-year cumulative risk of cervical intraepithelial neoplasia grade 3 or cancer. American Journal of Obstetrics and Gynecology 191: 1590-1597, 2004.
3. Cavalcanti SMB, Zardo LG, Passos MRL Oliveira LHS. Epidemiological aspects of Human papillomavirus infection and cervical cancer in Brazil. Journal of Infection 40: 80-87, 2000.
4. Clavel C, Masure M, Bory JP, Putaud I, Mangeonjean C, Lorenzato M, Nazeyrollas P, Gabriel R, Quereux C, Birembaut P. Human papillomavirus testing in primary screening for the detection of cervical lesions: a study of 7932 women. British Journal of Cancer 84: 1616-1623, 2001.
5. Cope JU, Hildesheim A, Schiffman MH, Manos MM, Lorincz AT, Burk RD, Glass AG, Greer C, Scott DR, Sherman M, Kurman RJ, Liaw KL. Comparison of th hybrid capture test and PCR for the detection of HPV DNA in Cervical specimens. Journal of Clinical Microbiology 35: 2262-2265, 1997.
6. Cox JT, Lorincz AT, Schiffman MH. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of ASCUS . American Journal of Obstetrics and Gynecology 172: 946-954, 1995.
7. Dillner J. Trends over time in the incidence of cervical neoplasia in comparison to trends over time in human papillomavirus infection. Journal of Clinical Virology 47: 649-652, 2000.
8. Farthing A, Masterson P, Mason WP, Vousden KH Human papillomavirus detection by hybrid capture and its possible clinical use. Journal of Clinical Pathology 47: 649-652, 1994.
9. Ferenczy A. Viral testing for genital papillomavirus infection. International Journal of Gynecological Cancer 5: 321-328, 1995.
10. Gilbert SM. Extensive Condylomata Acuminata: Medical and Surgical Management. Journal of Urology 16: 65-76, 2003.
11. Iftner T, Villa LL. Human papillomavirus technologies. Chapter 12. Journal of the National Cancer Institute Monographs 31: 80-88, 2003.
12. Illescas L. Captura Híbrida: Actualización. Gineconet, SA. http://www.gineconet.com, 2001.
13. Koutsky LA, Holmes KK, Critchlow CW, Stevens CE, Paavonen J, Beckman AM, DeRouen TA, Galloway DA, Vernon D, Kiviat NB. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 and 3 in relation to papillomavirus infection. New England Journal of Medicine 327:1272-1278, 1992.
14. Lopes ER, Rebelo, MS, Abreu E, Silva, VLC, Eisenberg ALA, Lavor MF. Comportamento da população brasileira feminina em relação ao câncer cérvico-uterino. Jornal Brasileiro de Ginecologia 105: 505-515, 1995.
15. Manos MM, Kinney WK, Hurley LB. Identifying women with cervical neoplasia using human papillomavirus testing for equivocal Papanicolaou results. Journal of American Medical Association 281: 1605-1610, 1999.
16. Molijn A, Kleter B, Quint W, van Doorn LJ. Molecular dignosis of Human papillomavirus infections. Journal of Clinical Virology, 325: S43-S51, 2005.
17. Muñoz N. Human papillomavirus infection and cancer: the epidemiological evidence. Jornal of Clinical Virology 19: 1-5, 2000.
18. Muñoz N, Bosch X, Sanjos, S, Herrero R, Castellsague X, Shahk V, Snijders PJF, Mujer CJLM. Epidemiologic classification of human papillomavirus types associated with cervical cancer. The New England Journal of Medicine 348: 518-527, 2003.
19. Oliveira LHS, Rodrigues EVM, Pantaleão JA, Lopes APTAS, Cavalcanti SMB. Human papillomavirus and co-factors to cervical cancer among women attended at University Hospital of Universidade Federal Fluminense. Jornal Brasileiro de Doenças Sexualmente Transmissíveis 14: 23-27, 2002.
20. Poljak M, Marin IJ, Seme K, Vince A. Hybrid capture II HPV Test detects at least 15 human papillomavirus genotypes not included in its current high-risk probe cocktail. Journal of Clinical Microbiology 25: S89-S97, 2002.
21. Smith AE, Sherman ME, Scott DR, Tabbara SO, Dworkin L, Olson J, Thompson J, Faser C, Snell J, Schiffman M. Review of the Bethesda Syistem Atlas does not improve reproducibility or accuracy in the classification of atypical squamous cells of undetermined significance smears. Cancer Cytopathology 90: 201-206, 2000.
22. Sun CA, Liu JF, Wu DM, Nieh S, Yu CP, Chu TY. Viral load of high risk human papillomavirus in cervical squamous intraepithelial lesions. International Journal Gynecology and Obstetrics 76: 41-47, 2002.
23. Terry G, Ho L, Londesborough P, Cusick J, Lohnas IM, Lorincz. Detection of high-risk HPV types by the hybrid capture 2 test. Journal of Medical Virology 65: 155-162, 2001.